RINAT NEUROSCIENCE CORP.
Patent Owner
Stats
- 37 US PATENTS IN FORCE
- 4 US APPLICATIONS PENDING
- Feb 15, 2018 most recent publication
Details
- 37 Issued Patents
- 0 Issued in last 3 years
- 0 Published in last 3 years
- 2,357 Total Citation Count
- Oct 06, 2003 Earliest Filing
- 21 Expired/Abandoned/Withdrawn Patents
Patent Activity in the Last 10 Years
Technologies
Intl Class
Technology
Matters
Rank in Class
Top Patents (by citation)
Upgrade to the Professional Level to View Top Patents for this Owner. Learn More |
Recent Publications
Publication #
Title
Filing Date
Pub Date
Intl Class
2017/0313,787 ENGINEERED POLYPEPTIDE CONJUGATES AND METHODS FOR MAKING THEREOF USING TRANSGLUTAMINASEMay 11, 17Nov 02, 17[C07K]
2015/0269,312 SYSTEMS AND METHODS OF SENSING AND ANALYZING ANTIBODY BLOCKING INTERACTIONSDec 02, 14Sep 24, 15[G01N, G06F]
Recent Patents
Patent #
Title
Filing Date
Issue Date
Intl Class
9676871 Engineered polypeptide conjugates and methods for making thereof using transglutaminaseNov 03, 11Jun 13, 17[A61K, C07K]
9527926 Heterodimeric proteins and methods for producing and purifying themMay 13, 11Dec 27, 16[A61K, C07K]
9498530 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameJul 19, 13Nov 22, 16[A61K, C07K]
9346885 Method of treating type 1 diabetes with antagonist IL-7 receptor antibodiesDec 17, 13May 24, 16[A61K, C07K]
9340610 Methods for treating osteoarthritis pain by administering a nerve growth factor antagonist and compositions containing the sameJul 19, 13May 17, 16[A61K, C07K]
9249224 Human growth hormone receptor antagonist antibodies and methods of use thereofDec 10, 12Feb 02, 16[A61K, C07K]
Expired/Abandoned/Withdrawn Patents
Patent #
Title
Status
Filing Date
Issue/Pub Date
Intl Class
2013/0236,451 ANTIBODIES DIRECTED AGAINST AMYLOID-BETA PEPTIDE AND METHODS USING SAMEAbandonedFeb 14, 13Sep 12, 13[C07K]
2011/0281,348 AGONIST ANTI-TRKC ANTIBODIES AND METHODS USING SAMEAbandonedMay 13, 11Nov 17, 11[C12N, C07K]
7935342 Methods for treating obesity by administering a trkB antagonistExpiredJan 29, 07May 03, 11[A61K]
2011/0038,861 Methods of Treating Alzheimer's Disease Using Antibodies Directed Against Amyloid Beta Peptide and Compositions ThereofAbandonedJun 30, 10Feb 17, 11[A61K, A61P]
2010/0196,390 AGONIST ANTI-TRKB MONOCLONAL ANTIBODIESAbandonedFeb 01, 10Aug 05, 10[A61K, C12N, A61P, C07K]
7655231 Methods for treating pain by administering a nerve growth factor antagonist and an NSAIDExpiredFeb 19, 04Feb 02, 10[A61K, C12P, C07K]
2009/0291,897 METHODS FOR TREATING UNWANTED WEIGHT LOSS OR EATING DISORDERS BY ADMINISTERING A TRKB AGONISTAbandonedJul 23, 09Nov 26, 09[A61K, A61P]
2009/0203,610 METHODS OF TREATING OBESITY OR DIABETES USING NT-4/5AbandonedMar 13, 09Aug 13, 09[A61K]
2007/0275,374 Methods For Idendifying Drug Targets And Modulators Of Neurons and Compositions Comprising The SameAbandonedMar 17, 04Nov 29, 07[C12Q, C12M, G01N]
2007/0160,616 Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereofAbandonedJan 12, 07Jul 12, 07[A61K]
2007/0031,418 Methods for treating lower motor neuron diseases and compositions containing the sameAbandonedApr 26, 06Feb 08, 07[A61K]
2006/0147,450 Methods for treating cardiac arrhythmia and preventing death due to cardiac arrhythmia using ngf antagonistsAbandonedOct 06, 03Jul 06, 06[A61K]
2006/0147,932 Methods of screening for modulators of nerve growth factorAbandonedJan 20, 04Jul 06, 06[C12Q, G01N]
2005/0089,521 Methods for treating taxol-induced sensory neuropathyAbandonedDec 23, 03Apr 28, 05[A61K]
2004/0146,512 Methods of treating Alzheimer's disease using antibodies directed against amyloid beta peptide and compositions thereofAbandonedOct 09, 03Jul 29, 04[A61K]
Top Inventors for This Owner
Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More |
We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.